BioCentury
ARTICLE | Company News

AlphaRx, Select Therap deal

November 18, 2002 8:00 AM UTC

ALRX signed a letter of intent to exclusively sub-license worldwide rights to a natural toxin, VeroPulse, from XZL to use as a cancer therapeutic. ALRX said the toxin has shown ability to selectively ...